NCT04876781
- Conditions
- Active Ankylosing Spondylitis, Active Moderate to Severe Rheumatoid Arthritis, Active Psoriatic Arthritis
- Locations
-
- Pfizer Seoul, South Korea
Clinical trial condition
Active Ankylosing Spondylitis
Explore clinical trials studying Active Ankylosing Spondylitis. Study availability and eligibility vary by location and protocol.
6 public trials
2 recruiting studies
Active Ankylosing Spondylitis trial results
NCT07172360
- Conditions
- Active Ankylosing Spondylitis
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
NCT05212051
- Conditions
- Active Ankylosing Spondylitis
- Locations
-
- Anhui Provincial Hospital Hefei, Anhui, China
- Beijing University Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Xiamen University Shamen, Fujian, China
- Sun Yat-sen Memorial Sun Yat-sen University City: Guangzhou Guangzhou, Guangdong, China
Completed
Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
NCT05814939
- Conditions
- Active Ankylosing Spondylitis
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
NCT05407246
- Conditions
- Active Ankylosing Spondylitis
- Locations
-
- The First Affiliated Hospital of Bengbu Medical University Hefei, Anhui, China
- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
- The Third Affiliated Hospital of Sun Yat sen University Guangzhou, Guangdong, China
- Conditions
- Active Ankylosing Spondylitis, Active Psoriatic Arthritis, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- Ra0098 116 Mesa, Arizona, United States
- Ra0098 107 Mesa, Arizona, United States
- Ra0098 135 Phoenix, Arizona, United States
- Ra0098 119 Tucson, Arizona, United States